Bhattacharya's nomination, alongside Robert F. Kennedy Jr. and Mehmet Oz, indicates potential shifts in vaccine policy under ...

The Singapore facility is part of Sanofi's 900 million euro investment to develop two new EVFs globally over five years. The ...

Bhattacharya, a Stanford University professor, has been a vocal critic of COVID-19 lockdowns and vaccine mandates. His ...

The announcements came Friday night, one after another, President-elect Donald Trump’s picks for the country’s premier health ...

Additional research on using vaccines in this way is needed. Tetanus, diphtheria, mumps, and polio are examples of diseases that were once common but are now rarely seen in the U.S. Even if ...

A presentation at the National Community Pharmacists Association Annual Meeting and Exposition focused on the latest on COVID ...

Opinion: Pro-vaccine advocates facing RFK Jr. are stronger, savvier, and more ready for a fight than ever before.

Ashish Jha, the former White House Covid-19 response coordinator, discusses the country's successes and mistakes.

As the biopharma industry braces for a second term under President-elect Donald Trump, speculation is swirling around the ...

“The net effect is that you have lower levels of antibodies because some of them don’t work anymore. A really good booster ...

The Ashanti Regional Health Directorate has announced that it is ready to commence the second phase of the polio vaccination ...

If he is confirmed as H.H.S. secretary, the longtime vaccine critic would be in a position to change the government’s ...